NCT06185634 is a NA clinical trial of Dietary intervention - Pasta at dinner in Normal Weight, sponsored by Azienda Ospedaliero-Universitaria Careggi.

Who is sponsoring NCT06185634?

NCT06185634 is sponsored by Azienda Ospedaliero-Universitaria Careggi.

What drugs are being tested in NCT06185634?

Interventions in NCT06185634: Dietary intervention - Pasta at dinner, Dietary intervention - Pasta at lunch.

What condition does NCT06185634 study?

NCT06185634 studies Normal Weight.

Is NCT06185634 still recruiting?

NCT06185634 is currently status unknown. Last updated 9 January 2024.

Last reviewed 2024-01-09 · How we verify

NCT06185634

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of the Timing of Pasta Consumption on Health

Status unknown NA Last updated 9 January 2024

What this trial tests

NA trial testing Dietary intervention - Pasta at dinner in Normal Weight in 70 participants. Status unknown.

Timeline

13 November 2023

Primary endpoint
13 November 2025

13 November 2025

Quick facts

Lead sponsor	Azienda Ospedaliero-Universitaria Careggi
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	70
Start date	13 November 2023
Primary completion	13 November 2025
Estimated completion	13 November 2025
Sites	1 location across Italy

Drugs / interventions tested

Dietary intervention - Pasta at dinner
Dietary intervention - Pasta at lunch

Conditions studied

Normal Weight — all drugs for Normal Weight →

Sponsor

Azienda Ospedaliero-Universitaria Careggi — full company profile →

Who can join

Adults 18 to 65, any sex, with Normal Weight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To date, the optimal timing for pasta consumption remains uncertain. Based on recent evidence in the field of chrono-nutrition, it is speculated that eating pasta at dinner may have a negative impact on cardio-metabolic health. Carbohydrate intake during a period of minimal glucose tolerance could potentially alter the glycaemic profile and increase the risk of overweight and obesity. Conversely, other studies indicate that consuming carbohydrates at dinner may enhance sleep efficiency and quality. Thus, the aim of this study is, for the first time, to evaluate whether there are discernible differences between consuming pasta at lunch or dinner for the human health.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The impact of the timing of pasta intake on sleep quality and health outcomes: a protocol for a randomized controlled trial.
Lotti S, Dinu M, Napoletano A, Pagliai G, et al · · 2025 · cited 1× · PMID 40340858 · DOI 10.1186/s13063-025-08859-x
The Impact of the Timing of Pasta Intake on Sleep Quality and Health Outcomes: A Protocol for a Randomized Controlled Trial
Lotti S, Dinu M, Napoletano A, Pagliai G, et al · · 2025 · DOI 10.21203/rs.3.rs-5282052/v1

Verify or expand the search:

Other recruiting trials for Normal Weight

Currently open trials in the same condition.

NCT06752967 — Hormonal Control of Energy and Macronutrient Intake in Obesity (MEMORY) · NA · recruiting
NCT06487832 — Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness · NA · recruiting
NCT04149288 — Olive Oil Polyphenols and Cardiovascular Health Biomarkers · NA · active not recruiting

Other Azienda Ospedaliero-Universitaria Careggi trials

Trials by the same sponsor.

NCT07296055 — Endobronchial Valve in Tubercular and NTM Pulmonary Cavities. · NA · not yet recruiting
NCT07289581 — Effect of Treatment With Butyric Acid in Anorexia Nervosa · NA · active not recruiting
NCT06978608 — Ultrasound and Somatosensory Median Nerve Evaluation in CRPS I · not yet recruiting
NCT07005882 — Hormonal Receptor (HR)-Positive HER2 Negative Breast Cancer Patients Treated With Preoperative ELacestrant and PULSAR Ra · Phase 2 · not yet recruiting
NCT06529601 — Comparison Between CAD/CAM and Conventional Mandibular Fixed Retainers. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06185634 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliero-Universitaria Careggi
Last refreshed: 9 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06185634.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing